Aβ toxicity in Alzheimer's disease: Globular oligomers (ADDLs) as new vaccine and drug targets

Neurochemistry International

Volumn 41, Issue 5, 2002, Pages 345-352

  Klein, William L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Amyloid; Degenerative disease; Protein misfolding

Indexed keywords

AMYLOID BETA PROTEIN; GLOBULAR OLIGOMER; OLIGOMER; UNCLASSIFIED DRUG; VACCINE;

ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; BRAIN TISSUE; CEREBELLUM; COGNITIVE DEFECT; DISEASE COURSE; DRUG SYNTHESIS; DRUG TARGETING; FRONTAL CORTEX; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY MECHANISM; TRANSGENIC MOUSE; ANIMAL; DRUG EFFECT; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALIA; MUS MUSCULUS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; HUMANS; SIGNAL TRANSDUCTION; VACCINES;

EID: 0035993237     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(02)00050-5     Document Type: Article

References (49)

1. Amyloid-beta-protein oligomerization: Prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins
2. Methodological variables in the assessment of beta amyloid neurotoxicity
3. Nonfibrillar Aβ toxins in AD: An immunoassay to characterize ADDL formation and identify ADDL-blocker compounds
4. Self-assembly of Aβ 1-42 into globular neurotoxins (ADDLs)
5. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation
6. Alzheimer's disease and transgenic mice
7. Wnt signaling function in Alzheimer's disease
8. Spatial learning deficit in mice expressing human 751-amino acid beta-amyloid precursor protein
9. Behavioral deficits in APP(V717F) transgenic mice deficient for the apolipoprotein E gene
10. Nonfibrillar Aβ toxins in Alzheimer's pathogenesis: Presence of ADDLs and ADDL-binding proteins in Alzheimer's disease brains
11. Protofibrillar intermediates of amyloid-beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons
12. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
13. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: Lack of association with amyloid deposits
14. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models
15. Aβ toxicity in Alzheimer's Disease
16. Targeting small Abeta oligomers: The solution to an Alzheimer's disease conundrum?
17. Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation
18. Diffusible, nonfibrillar ligands derived from Abeta 1-42 are potent central nervous system neurotoxins
19. Beta/A4-evoked degeneration of differentiated SH-SY5Y human neuroblastoma cells
20. Vaccination with soluble Aβ oligomers generates toxicity-neutralizing antibodies
21. Structural neurology: Are seeds at the root of neuronal degeneration?
22. Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice
23. Insulin transiently increases tau phosphorylation: Involvement of glycogen synthase kinase-3beta and fyn tyrosine kinase
24. Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis
25. Reversible inactivation of superoxide-sensitive aconitase in Aβ 1-42-treated neuronal cell lines
26. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons
27. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red
28. Soluble amyloid-beta peptide concentration as a predictor of synaptic change in Alzheimer's disease
29. Apoptotic biochemical cascades in synaptic compartments: Roles in adaptive plasticity and neurodegenerative disorders
30. The plasticity-pathology continuum: Defining a role for the LTP phenomenon
31. Abeta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
32. High-level neuronal expression of Abeta 1-42 in wild-type human amyloid protein precursor transgenic-mice: Synaptotoxicity without plaque formation
33. Purification and characterization of brain clusterin
34. Clusterin (Apoj) alters the aggregation of amyloid-beta-peptide (Abeta 1-42) and forms slowly sedimenting Abeta complexes that cause oxidative stress
35. Aberrant stress response associated with severe hypoglycemia in a transgenic mouse model of Alzheimer's disease
36. Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state
37. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
38. The protein tyrosine kinase, fyn, in Alzheimer's disease pathology
39. Protein synthesis at synaptic sites on dendrites
40. The nanometer-scale structure of amyloid-beta visualized by atomic force microscopy
41. The neuropathology of Alzheimer disease and the structural basis of its cognitive alterations
42. Amyloid-beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates
43. Amyloid-beta-protein fibrillogenesis: Detection of a protofibrillar intermediate
44. Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus
45. Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory
46. The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from beta-amyloid-induced cell death by inhibiting the formation of beta-amyloid-derived diffusible neurotoxic ligands
47. The role of Abeta 42 in Alzheimer's disease
48. Morphological changes in dendritic spines associated with long-term synaptic plasticity
49. Abeta peptide enhances focal adhesion kinase/fyn association in a rat CNS nerve cell line